Author: Barison, Andrea; Aimo, Alberto; Castiglione, Vincenzo; Arzilli, Chiara; Lupón, Josep; Codina, Pau; Santiago-Vacas, Evelyn; Cediel, Germán; Emdin, Michele; Bayes-Genis, Antoni
Title: Cardiovascular disease and COVID-19: les liaisons dangereuses Cord-id: 7cw75bp2 Document date: 2020_5_11
ID: 7cw75bp2
Snippet: Patients with cardiovascular risk factors or established cardiovascular disease have an increased risk of developing coronavirus disease 19 and have a worse outcome when infected, but translating this notion into effective action is challenging. At present it is unclear whether cardiovascular therapies may reduce the likelihood of infection, or improve the survival of infected patients. Given the crucial importance of this issue for clinical cardiologists and all specialists dealing with coronav
Document: Patients with cardiovascular risk factors or established cardiovascular disease have an increased risk of developing coronavirus disease 19 and have a worse outcome when infected, but translating this notion into effective action is challenging. At present it is unclear whether cardiovascular therapies may reduce the likelihood of infection, or improve the survival of infected patients. Given the crucial importance of this issue for clinical cardiologists and all specialists dealing with coronavirus disease 19, we tried to recapitulate the current evidence and provide some practical recommendations.
Search related documents:
Co phrase search for related documents- accurate estimation and lopinavir ritonavir: 1
- accurate estimation and lung disease: 1, 2
- ace pathway and acute ards respiratory distress syndrome: 1, 2
- ace pathway and acute ards respiratory distress syndrome complication: 1
- ace pathway and acute cardiac injury: 1
- ace pathway and acute lung injury: 1, 2
- ace pathway and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- ace pathway and lung injury: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date